Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review

References

• Conway DI, Purkayastha M, Chestnutt IG. The changing epidemiology of oral cancer : definitions, trends, and risk factors. Nat Publ Gr. 2018;225(9):867–873.
   Google Scholar
• Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102: 104550.
   PubMed Web of Science ®Google Scholar
• World Health Organization. GLOBOCAN 2020 [Internet]. Cancer today. 2020. Available from: https://gco.iarc.fr/today/home
   Google Scholar
• Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018 Aug;47(7):633–640.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov 1;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Sarode G, Maniyar N, Sarode SC, et al. Epidemiologic aspects of oral cancer. Disease-a-Month. 2020;66(12):100988.
   PubMed Web of Science ®Google Scholar
• Jin LJ, Lamster IB, Greenspan JS, et al. Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis. 2016 Oct;22(7):609–619.
   PubMed Web of Science ®Google Scholar
• Ghani WMN, Ramanathan A, Prime SS, et al. Survival of oral cancer patients in different ethnicities. Cancer Invest. 2019;37(7):275–287.
   PubMed Web of Science ®Google Scholar
• Capote-Moreno A, Brabyn P, Muñoz-Guerra MF, et al., Oral squamous cell carcinoma: epidemiological study and risk factor assessment based on a 39-year series. Int J Oral Maxillofac Surg. 49(12): 1525–1534. 2020.
   PubMed Web of Science ®Google Scholar
• Tirelli G, Gatto A, Bonini P, et al. Prognostic indicators of improved survival and quality of life in surgically treated oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jan;126(1):31–40.
   Web of Science ®Google Scholar
• Speight PM, Epstein J, Kujan O, et al. Screening for oral cancer-a perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jun;123(6):680–687.
   PubMed Web of Science ®Google Scholar
• Nikitakis NG, Pentenero M, Georgaki M, et al. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):650–669.
   PubMed Web of Science ®Google Scholar
• Rai V, Mukherjee R, Ghosh AK, et al. “Omics” in oral cancer: new approaches for biomarker discovery. Available from Arch Oral Biol. 2018;87February2017:15–34.
   PubMedGoogle Scholar
• Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018 Feb;243(3):213–221.
   PubMed Web of Science ®Google Scholar
• Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, et al. Saliva diagnostics – current views and directions. Exp Biol Med. 2017;242(5):459–472.
   PubMed Web of Science ®Google Scholar
• Chi LM, Hsiao YC, Chien KY, et al. Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry. J Proteomics. 2020;211:103571.
   PubMed Web of Science ®Google Scholar
• Lee LT, Wong YK, Hsiao HY, et al. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(6):699–707.
   PubMed Web of Science ®Google Scholar
• Amenabar JM, Da Silva BM, Punyadeera C. Salivary protein biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2020;1–9.
   Web of Science ®Google Scholar
• Adeoye J, Brennan PA, Thomson P. “Search less, verify more”-Reviewing salivary biomarkers in oral cancer detection. J Oral Pathol Med. 2020;49(8): 711–719.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S. Risk assessment in oral cancer. Springer; 2020. p. 119–132.
   Google Scholar
• Al Moustafa AE. Development of oral cancer. 2017.
   Google Scholar
• Diajil A, Thomson P Risk factors of oral cancer and potentially malignant disorders (PMDs) – developing a high/low risk profiling system. 2016.
   Google Scholar
• Arellano-Garcia ME, Hu S, Wang J, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008 Nov;14(8):705–712.
   PubMed Web of Science ®Google Scholar
• Babiuch K, Kuśnierz-Cabala B, Kęsek B, et al. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. J Clin Med. 2020;9(3):867.
   Web of Science ®Google Scholar
• Bagan L, Sáez GT, Tormos MC, et al. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia. Clin Oral Investig. 2016;20(4):737–743.
   PubMed Web of Science ®Google Scholar
• Brinkmanna O, Kastratovicb DA, Milovan V, et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2012;47(1):51–55.
   Web of Science ®Google Scholar
• Gleber-Netto FO, Yakob M, Li F, et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res. 2016;22(13):3340–3347.
   PubMed Web of Science ®Google Scholar
• Hamad AWR, Gaphor SM, Shawagfeh MT, et al. Study of serum and salivary levels of proinflammatory cytokines, potential biomarkers in the diagnosis of oral squamous cell carcinoma. Acad J Cancer Res. 2011;4(2):47–55.
   Google Scholar
• Hamzavi M, Tadbir AA, Rezvani G, et al. Tissue expression, serum and salivary levels of IL-10 in patients with head and necksquamous cell carcinoma. Asian Pacific J Cancer Prev. 2013;14(3):1681–1685.
   PubMed Web of Science ®Google Scholar
• Khyani IAM, Qureshi MA, Mirza T, et al. Detection of interleukins-6 and 8 in saliva as potential biomarkers of oral pre-malignant lesion and oral carcinoma: a breakthrough in salivary diagnostics in Pakistan. Pak J Pharm Sci. 2017 May;30(3):817–823.
   PubMed Web of Science ®Google Scholar
• Korostoff A, Reder L, Masood R, et al. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol. 2011;47(4):282–287.
   PubMed Web of Science ®Google Scholar
• Lisa Cheng Y-S, Jordan L, Gorugantula LM, et al. Salivary interleukin-6 and −8 in patients with oral cancer and patients with chronic oral inflammatory diseases. J Periodontol. 2014;85(7):956–965.
   PubMed Web of Science ®Google Scholar
• Panneer Selvam N, Sadaksharam J. Salivary interleukin-6 in the detection of oral cancer and precancer. Asia Pac J Clin Oncol. 2015;11(3):236–241.
   PubMed Web of Science ®Google Scholar
• Punyani SR, Sathawane RS. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma. Clin Oral Investig. 2013;17(2):517–524.
   PubMed Web of Science ®Google Scholar
• Rajkumar K, Nandhini G, Ramya R, et al. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(3):309–319.
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Cheng B, Myers S, et al. The feasibility of monitoring NF-κB associated cytokines: TNF-α, IL-1α, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog. 2005;44(2):77–82.
   PubMed Web of Science ®Google Scholar
• Sahebjamee M, Eslami M, Atarbashimoghadam F, et al. Salivary concentration of TNF? IL1? IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2008;13(5):292–295.
   Web of Science ®Google Scholar
• Sharma M, Bairy I, Pai K, et al. Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis. Clin Oral Investig. 2011;15(5):705–714.
   PubMed Web of Science ®Google Scholar
• Singh P, Verma JK, Singh JK. Validation of salivary markers, IL-1β, IL-8 and Lgals3bp for detection of oral squamous cell carcinoma in an Indian population. Sci Rep. 2020 Apr;10(1):7365.
   PubMed Web of Science ®Google Scholar
• St. John MAR, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol - Head Neck Surg. 2004;130(8):929–935.
   PubMedGoogle Scholar
• Tan W, Sabet L, Li Y, et al. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron. 2008;24(2):266–271.
   PubMed Web of Science ®Google Scholar
• Lee LT, Wong YK, Hsiao HY, et al. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(6):699–707.
   PubMed Web of Science ®Google Scholar
• Hu SY, Lin MH, Yang SC, et al. Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9. J Formos Med Assoc. 2005;2(104):113–119.
   Google Scholar
• Krishnan R, Thayalan DK, Padmanaban R, et al. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease. Asian Pacific J Cancer Prev. 2014;15(17):7141–7148.
   PubMedGoogle Scholar
• Liu SY, Lin MH, Yang SC, et al. Increased expression of matrix metalloproteinase-2 in oral cells after short-term stimulation and long-term usage of areca quid. J Formos Med Assoc. 2005;06(104):390–397.
   Google Scholar
• Wang Q, Gao P, Cheng F, et al. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry. Talanta. 2014;119:299–305.
   PubMed Web of Science ®Google Scholar
• De Souza MB, De Carvalho MB, De Carvalho MB, et al. Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma. Oncol Lett. 2014;8(5):2267–2275.
   PubMed Web of Science ®Google Scholar
• El-Naggar AK, Mao L, Staerkel G, et al., Genetic heterogeneity in saliva from patients with oral squamous carcinomas. J Mol Diagnostics. 3(4): 164–170. 2001.
   PubMed Web of Science ®Google Scholar
• Pierce Campbell CM, Giuliano AR, Torres BN, et al. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: the cancer prevention study II nutrition cohort. Oral Oncol. 2016;55:1–5.
   PubMed Web of Science ®Google Scholar
• Polz-Dacewicz M, Strycharz-Dudziak M, Dworzański J, et al. Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections. Infect Agent Cancer. 2016;11(1):1–8.
   PubMedGoogle Scholar
• Rettori MM, De carvalho AC, Bomfim longo AL, et al. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis. 2013;34(1):20–27.
   PubMed Web of Science ®Google Scholar
• Bernardes VF, Gleber-Netto FO, Sousa SF, et al. EGF in saliva and tumor samples of oral squamous cell carcinoma. Appl Immunohistochem Mol Morphol. 2011;19(6):528–533.
   PubMedGoogle Scholar
• Aziz S, Ahmed SS, Ali A, et al. Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients. Cancer Invest. 2015;33(7):318–328.
   PubMed Web of Science ®Google Scholar
• Jiang WW, Masayesva B, Zahurak M, et al. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res. 2005;11(7):2486–2491.
   PubMed Web of Science ®Google Scholar
• Jiang WW, Rosenbaum E, Mambo E, et al. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res. 2006;12(5):1564–1569.
   PubMed Web of Science ®Google Scholar
• Sayall L, Mashlah A, Kassem I. Evaluation of mitochondrial DNA content in saliva of oral squamous cell carcinoma and leukoplakia as non-invasive biomarker. Int J PharmTech Res. 2015;7(4):573–579.
   Google Scholar
• Bernardes VF, Gleber-Netto FO, Sousa SF, et al. Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study. J Exp Clin Cancer Res. 2010;29(1):1–7.
   PubMedGoogle Scholar
• Demokan S, Chang X, Chuang A, et al. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer. 2010;127(10):2351–2359.
   PubMed Web of Science ®Google Scholar
• Arduino PG, Menegatti E, Cappello N, et al. Possible role for interleukins as biomarkers for mortality and recurrence in oral cancer. Int J Biol Markers. 2015;30(2):e262–6.
   PubMed Web of Science ®Google Scholar
• Brailo V, Vučićević-Boras V, Cekić-Arambašin A, et al. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. Oral Oncol. 2006;42(4):370–373.
   PubMed Web of Science ®Google Scholar
• Yu J-S, Chen Y-T, Chiang W-F, et al. Saliva protein biomarkers To detect oral squamous cell carcinoma in a high-risk population in Taiwan. Proc Natl Acad Sci U S A. 2016;113(41):11549–11554.
   PubMed Web of Science ®Google Scholar
• Zanotti L, Paderno A, Piazza C, et al. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer. Laryngoscope. 2017;127(11):E408–14.
   PubMed Web of Science ®Google Scholar
• Wang Q, Gao P, Wang X, et al. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta. 2014;427:79–85.
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Ho V, Miller CS, et al. NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29(1):42–45.
   PubMedGoogle Scholar
• Brailo V, Vucicevic-Boras V, Lukac J, et al. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal. 2012;17(1):6–11.
   Web of Science ®Google Scholar
• Juretić M, Cerović R, Belušić-Gobić M. et al. Salivary levels of TNF-α and IL-6 in patients with oral premalignant and malignant lesions. Folia Biol. 2013;59(2):99–102.
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Henrique R, Jeronimo C, et al. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res. 2011;17(14):4782–4789.
   PubMed Web of Science ®Google Scholar
• Franzmann EJ, Reategui EP, Carraway KL, et al. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(3):735–739.
   PubMed Web of Science ®Google Scholar
• Heawchaiyaphum C, Pientong C, Phusingha P, et al. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches. J Proteomics. 2018;173:52–61.
   PubMed Web of Science ®Google Scholar
• Franzmann EJ, Reategui EP, Mateus Pereira LH, et al. Salivary protein and solcd44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head Neck. 2012;34(5):687–695.
   PubMed Web of Science ®Google Scholar
• Ganesan A, Gautham Kumar N. Assessment of lipid peroxides in multiple biofluids of leukoplakia and oral squamous cell carcinoma patients - A clinico- biochemical study. J Clin Diagn Res. 2014;8(8):10–13.
   Google Scholar
• Sivaramakrishnan M, Sivapathasundharam B, Jananni M. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients. J Oral Pathol Med. 2015;44(6):449–452.
   PubMed Web of Science ®Google Scholar
• Liyanage C, Wathupola A, Muraleetharan S, et al. Promoter Hypermethylation of Tumor-Suppressor Genes p16(INK4a), RASSF1A, TIMP3, and PCQAP/MED15 in Salivary DNA as a Quadruple Biomarker Panel for Early Detection of Oral and Oropharyngeal Cancers. Biomolecules. 2019;9(4):148.
   PubMed Web of Science ®Google Scholar
• Raffat MA, Hadi NI, Hosein M, et al. Differential expression of salivary S100A7 in oral submucous fibrosis. Saudi Dent J. 2019;31(1):39–44.
   PubMed Web of Science ®Google Scholar
• Lim Y, Wan Y, Vagenas D, et al., Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers. BMC Cancer. 16(1): 1–12. 2016.
   Google Scholar
• Sato J, Ohuchi M, Wada M, et al. Differences in sequential posttreatment salivary IL-6 levels between patients with and patients without locoregional recurrences of oral squamous cell carcinoma: part III of a cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(6):751–760.e2.
   PubMed Web of Science ®Google Scholar
• Vesty A, Gear K, Biswas K, et al. Microbial and inflammatory-based salivary biomarkers of head and neck squamous cell carcinoma. Clin Exp Dent Res. 2018 Nov 28;4(6):255–262.
   PubMed Web of Science ®Google Scholar
• Márton IJ, Horváth J, Lábiscsák P, Márkus B, Dezső B, Szabó A, Tar I, Piffkó J, Jakus P, Barabás J, Barabás P, Olasz L, Kövér Z, Tőzsér J, Sándor J, Csősz É, Scholtz B, Kiss C. Salivary IL-6 mRNA is a Robust Biomarker in Oral Squamous Cell Carcinoma. J Clin Med. 2019 Nov 13;8(11):1958. doi:10.3390/jcm8111958. PMID: 31766212; PMCID: PMC6912409
   Google Scholar
• Jayasooriya PR, Pitakotuwage TN, Lombardi T. Descriptive study of 896 Oral squamous cell carcinomas from the only University based Oral Pathology Diagnostic Service in Sri Lanka. BMC Oral Health. 2016 Jan 8;16(1). 10.1186/s12903-015-0139-y.
   PubMedGoogle Scholar
• Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011;57(5):675–687.
   PubMed Web of Science ®Google Scholar
• Katakura A, Kamiyama I, Takano N, et al. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll. 2007;48(4):199–203.
   PubMedGoogle Scholar
• Upile T, Jerjes W, Kafas P, et al. Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication. Int Arch Med. 2009;2(1):1–4.
   PubMedGoogle Scholar
• van der Merwe L, Wan Y, Cheong HJ, et al. A pilot study to profile salivary angiogenic factors to detect head and neck cancers. BMC Cancer. 2018 Jul;18(1):734.
   PubMedGoogle Scholar
• He H, Chen G, Zhou L, et al. A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland. J Cancer Res Clin Oncol. 2009;135(10):1315–1321.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Urs AB, Chakravarti A, et al. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumor Biol. 2016;37(7):9263–9271.
   PubMedGoogle Scholar
• Ghalwash DM, El GK, Zahran FM, et al. The diagnostic and prognostic value of salivary sCD44 level determination in oral malignant and potentially premalignant lesions. Adv Environ Biol. 2012;6(1):302–310.
   Google Scholar
• Lokesh K, Kannabiran J, Rao MD. Salivary lactate dehydrogenase (LDH)- A novel technique in oral cancer detection and diagnosis. J Clin Diagn Res. 2016;10(2):ZC34–7.
   PubMed Web of Science ®Google Scholar
• Totan A, Miricescu D, Parlatescu I, et al. Possible salivary and serum biomarkers for oral lichen planus. Biotech Histochem. 2015;90(7):552–558.
   PubMed Web of Science ®Google Scholar
• Sahibzada HA, Khurshid Z, Khan RS, et al. Salivary IL-8, IL-6 and TNF-α as potential diagnostic biomarkers for oral cancer. Diagnostics. 2017;7(2):21.
   Web of Science ®Google Scholar
• Dikova VR, Principe S, Bagan JV. Salivary inflammatory proteins in patients with oral potentially malignant disorders. J Clin Exp Dent. 2019 Jul;11(7):e659–64.
   PubMedGoogle Scholar
• Rezaei F, Mozaffari HR, Tavasoli J, et al. Evaluation of serum and salivary interleukin-6 and interleukin-8 levels in oral squamous cell carcinoma patients: systematic review and meta-analysis. J Interferon Cytokine Res. 2019 Dec;39(12):727–739.
   PubMed Web of Science ®Google Scholar
• Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054–1061.
   PubMed Web of Science ®Google Scholar
• Csosz É, Lábiscsák P, Kalló G, et al., Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers. PLoS One. 12(5): 1–22. 2017.
   Web of Science ®Google Scholar